No single probiotic has been proven to reliably treat a vaginal yeast infection on its own. Antifungal medication remains the standard first-line treatment. That said, a growing body of clinical research suggests that specific probiotic strains, used alongside antifungals, can speed symptom relief and significantly cut the chances of the infection coming back. If you’re dealing with recurring yeast infections, the strain details and timing matter more than grabbing any bottle off the shelf.
What the Research Actually Shows
The American College of Obstetricians and Gynecologists (ACOG) does not recommend probiotics for treating or preventing vaginal yeast infections, citing insufficient evidence. That’s important context. Most gynecologists will tell you to treat an active infection with an antifungal first.
However, several clinical trials published after those guidelines paint a more nuanced picture, particularly for women who get yeast infections repeatedly. In one randomized controlled trial, women who took probiotics after antifungal treatment had a 19% recurrence rate over 12 months, compared to 44% in the placebo group. That’s a 57% reduction in the odds of another infection. Another study found a 66% reduction in the first relapse rate just one month after treatment when probiotics were added. These aren’t probiotics replacing medication. They’re probiotics used as a follow-up strategy to keep infections from returning.
Strains With the Strongest Evidence
Not all probiotics contain strains relevant to vaginal health. The ones with the most clinical data behind them fall into a few categories.
Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14
This is the most studied combination for vaginal health. In a trial of 50 women with vaginal infections, oral supplementation with these two strains for 15 days (after antibiotic therapy) led to successful vaginal recolonization with protective lactobacilli in 92% of participants. These strains were specifically selected because they survive the digestive tract and migrate to the vaginal area, which is unusual for oral probiotics. You’ll find this combination in several commercially available supplements marketed for women’s health.
Lactobacillus crispatus
This species is the dominant bacterium in the healthiest vaginal microbiomes. Women whose vaginal flora is rich in L. crispatus tend to be more resistant to both yeast infections and bacterial vaginosis. Preclinical testing shows L. crispatus strains directly inhibit the growth of Candida, the fungus responsible for yeast infections. Multi-strain L. crispatus supplements are now available both as vaginal tablets and oral capsules, though the clinical trial data for this species is still catching up to the GR-1/RC-14 combination.
How Probiotics Fight Yeast Overgrowth
Lactobacillus bacteria don’t kill Candida the way an antifungal drug does. Instead, they work through several indirect mechanisms. They produce lactic acid and other compounds that lower vaginal pH, creating an environment where yeast struggles to thrive. They also physically compete with Candida for space on vaginal tissue, blocking the fungus from attaching and forming the biofilms it needs to establish an infection. Research shows that probiotic lactobacilli can interfere with a critical step in Candida’s lifecycle: the transition from harmless round yeast cells into the elongated filaments that actually invade tissue and cause symptoms.
Oral Capsules vs. Vaginal Suppositories
Probiotics for vaginal health come in two forms: oral capsules you swallow and vaginal suppositories or tablets inserted directly. Clinical trials have tested both routes, and the evidence suggests they work through different timelines. Vaginal application delivers bacteria directly where they’re needed, which makes colonization faster. Oral probiotics take a more indirect path, traveling through the gut and eventually reaching the vaginal area, but they also support the broader microbial ecosystem.
In a trial comparing the two approaches as add-ons to antifungal treatment, both oral and vaginal supplementation over four weeks contributed to eliminating yeast infection symptoms. The probiotic groups showed better recovery times than the antifungal-only group. Some researchers and supplement makers now recommend using both routes together for recurrent infections, and that’s the approach used in the trial that showed the 57% reduction in recurrence.
Dosage and Duration
Most successful clinical trials use a dose of around 1 to 2 billion colony-forming units (CFU) per day. A current large-scale trial testing probiotics specifically for recurrent yeast infections uses 2 billion CFU daily for six months. This is worth noting because many commercial probiotics advertise 10, 50, or even 100 billion CFU. More isn’t necessarily better for vaginal health, and the strains matter far more than the total count.
Duration is equally important. The studies showing meaningful reductions in recurrence used probiotics consistently for weeks to months, not days. The biggest benefits appeared at the three-month mark, when women using probiotics had nearly three times the recurrence-free survival rate compared to placebo (73% vs. 35%). If you’re trying probiotics to prevent recurring infections, plan on at least three months of daily use after your antifungal treatment to give the approach a fair shot.
What to Look for on the Label
When choosing a probiotic for this purpose, check for these specifics:
- Named strains, not just species. A label that says “Lactobacillus rhamnosus GR-1” tells you the exact strain tested in clinical trials. One that says only “Lactobacillus rhamnosus” could be any strain of that species, and most have never been studied for vaginal health.
- CFU count at expiration, not at manufacture. Bacteria die during shelf life. A product guaranteeing potency through the expiration date is more reliable than one listing CFU “at time of manufacture.”
- Strains relevant to vaginal flora. General gut-health probiotics containing Bifidobacterium or Saccharomyces strains aren’t the same thing. Stick with products containing Lactobacillus rhamnosus GR-1, L. reuteri RC-14, or L. crispatus.
Safety Considerations
For most healthy adults, Lactobacillus-based probiotics have an excellent safety profile. Serious side effects in clinical trials have been rare. The main concern is for people with weakened immune systems, such as those undergoing chemotherapy, taking immunosuppressive drugs, or living with uncontrolled HIV. In these populations, probiotics carry a small risk of causing bloodstream infections because the immune system can’t keep even “friendly” bacteria in check. If you fall into that category, talk with your doctor before starting any probiotic regimen.
One other caveat: probiotics containing Saccharomyces boulardii, a yeast-based probiotic sometimes used for gut health, have been linked to fungal bloodstream infections in hospitalized or critically ill patients. This strain is not appropriate for someone trying to address a yeast problem.